Opportunity Alert: Traction Accelerator (Apply by December 15th)

Are you an entrepreneur ready to grow your revenue? Join the Traction Accelerator and get the tools, training, and community you need to rapidly grow your business.

The Traction Accelerator is a 19-week intensive program with 7 months of mentoring that will help you identify your ideal customers, craft messaging that converts, build sales systems that scale, and create momentum for your startup.

You’ll get access to top-tier mentors, and a network of like-minded founders facing similar challenges. Walk away with a clear plan to acquire customers and generate revenue. CEI is so confident this program will accelerate your startup’s growth that if you complete the program and don’t increase your revenue, they’ll refund your money.

Applications for Traction Accelerator close December 15th!

Learn more and apply here: ceigateway.com/traction-accelerator/

For additional information, contact Patti DuBois at dubois@ceigateway.com

CancerX Launches New Startup Accelerator to Advance Digital Innovations in Oncology

TAMPA, Fla. – CancerX, co-hosted by Moffitt Cancer Center and the Digital Medicine Society (DiMe) alongside the Office of the National Coordinator for Health Information Technology and the Office of the Assistant Secretary for Health announced the launch of the CancerX Startup Accelerator today at the Future of Cancer Care Summit in Tampa, Fla. It is the first-ever national cancer innovation accelerator initiative with public support from the White House. 

Continue reading

C-Path’s Pioneering Neuroscience Workshop Transforms the Landscape of Neurological Disorder Therapies

TUCSON, Ariz., Nov. 9, 2023 – Critical Path Institute (C-Path) is pleased to announce the release of a new peer-reviewed publication, titled “Transforming Drug Development for Neurological Disorders: Proceedings from a Multi-disease Area Workshop,” now published in Neurotherapeutics, The Journal of the American Society for Experimental Neurotherapeutics.Continue reading

City of Hope appoints Alan H. Bryce, M.D., as chief clinical officer at City of Hope Cancer Center Phoenix and professor of molecular medicine at TGen

PHOENIX, NOVEMBER 7, 2023 — City of Hope®, one of the largest cancer research and treatment organizations in the United States, today announced the appointment of Alan H. Bryce, M.D., as the chief clinical officer at City of Hope Cancer Center Phoenix and professor of molecular medicine at Translational Genomics Research Institute (TGen), part of City of Hope. He joins City of Hope from Mayo Clinic, where he served as chair of the Division of Hematology and Medical Oncology in the Department of Internal Medicine at Mayo Clinic in Arizona and director of Mayo Clinic Comprehensive Cancer Center in Arizona. Continue reading